California-based Allergan informs state regulators that it plans to permanently lay off 129 employees.
Embattled aesthetic devices maker Allergan (NYSE:AGN) informed California state authorities that it plans to cut 129 workers over the next few weeks.
Massachusetts-based Accellent announces plans to close plants in Colorado and Ireland as the company integrates with Lake Region Medical.
Accellent is preparing to close doors on a couple manufacturing facilities as the device maker navigates its integration with Lake Region Medical Center.
Accellent said that it will close down a plant in Arvada, Colo., resulting in layoffs for some 200 workers. The company is also planning to consolidate a pair of Galway, Ireland, facilities into a single location, but hopes to keep most of those employees.
Invacare blames a poor 1st-half and "slow start" to Q3 for restructuring measures that will reduce its workforce by nearly 200 employees.
Ohio-based Invacare (NYSE:IVC) is conducting another round of layoffs as it continues to struggle through the year.
Analogic announces plans to lay off 50 workers from various departments in efforts to save $6 million.
MASSDEVICE ON CALL — Struggling Analogic (NSDQ:ALOG) announced this week that it will cut 50 jobs from various divisions in order to help cut costs in coming years.
The company didn't offer many details about the layoffs, but said that the measure will help reduce costs by about $6 million starting in Q1 2015.
Smith & Nephew confirms that it's cutting some of its U.K. manufacturing jobs and moving the positions to a plant in China.
St. Jude Medical informs California state regulators that it's planning to lay off 274 from a facility in Sylmar.
St. Jude Medical (NYSE:STJ) is about to hand out more than 270 pink slips to employees at a facility in Sylmar, Calif., according to a notice filed with the state's Employment Development Dept.
Botox-maker Allergan announces restructuring measures that will cut 13% of its global workforce as the company sinks deeper into a months-long battle against activist investors and attempts at a takeover.
Updated July 21, 2014, at 12:40 p.m. EST with additional information on Allergan's earnings.